Advertisement

Reactions Weekly

, Volume 1633, Issue 1, pp 24–24 | Cite as

Adalimumab/infliximab

Dermatological side effects: 3 case reports
Case report
  • 26 Downloads

Reference

  1. Pijls PARR, et al. Vedolizumab is an effective alternative in inflammatory bowel disease patients with anti-TNF-alpha therapy-induced dermatological side effects. Digestive and Liver Disease 48: 1391-1393, No. 11, Nov 2016. Available from: URL: http://doi.org/10.1016/j.dld.2016.08.122 - Netherlands

Copyright information

© Springer International Publishing Switzerland 2017

Personalised recommendations